Scutellaria baicalensis: benefits, dosage, contraindications

Anti-inflammatory

Skullcap shows significant anti-inflammatory activity, supported by in vitro and in vivo research. Its key components, baicalin and wogonin, influence various inflammatory factors, including cytokines, nitric oxide, and eicosanoids. Studies on mice have confirmed its efficacy in reducing several inflammatory markers, including those involved in allergic processes. Baicalin may act by inhibiting chemokines, while wogonin may reduce microglial cell mobility, partly via NF-baB inhibition.

Usages associés

Neurological

Numerous in vitro and in vivo trials have demonstrated the neuroprotective effects of flavonoids derived from skullcap. They suggest that skullcap flavones prevent neural damage through a strong antioxidant effect (reduction in lipid peroxidation markers), moderating inflammation and enhancing GABAergic signaling (anxiolytic and anticonvulsant effect) and that wogonin (a component of skullcap) exerts a neurogenerative action, based on in vitro and in vivo evidence. An in vivo study in rats subjected to permanent global ischemia showed that daily oral doses of skullcap flavonoids (35 mg/kg) for 19 to 20 days significantly increased learning and memory capacities and attenuated neuronal damage. A follow-up in vivo study demonstrated that the flavonoid fraction also reduced neuronal damage and memory deficits after permanent cerebral ischemia. Huang lian jie du tang is an important Chinese remedy based on multiple herbs, containing Scutellaria baicalensis, which is used clinically to treat cerebral ischemia. It also appears that skullcap may play a role in neurodegenerative disorders such as Parkinson's disease.

Usages associés

Anticancer

Skullcap is traditionally used in alternative medicine for cancer treatment, notably prostate cancer. Scientific studies, both on animals and in vitro, have explored its anticancer properties. These studies suggest that Skullcap induces apoptosis (programmed cell death) by inhibiting certain cellular pathways and reducing inflammatory cytokines and eicosanoids. Moreover, in vitro studies indicate that Skullcap might prevent the formation of new blood vessels feeding tumors, a process known as anti-angiogenesis, possibly through influence on specific signaling pathways.

Usages associés

Antiallergic

Various flavonoids of Baikal skullcap, including wogonin and baicalein, have demonstrated an ability to inhibit histamine release from rat mast cells. These flavonoids also attenuate allergic reactions, both immediate and delayed, by acting on IgE antibodies in mice and decreasing histamine release in human mast cells. Moreover, compounds like luteolin and baicalin reduce histamine and other inflammatory mediators. Skullcap proves to be as effective, if not more, than some conventional antiallergic medications in suppressing allergic reactions.

Usages associés

Antiviral

Scutellaria has demonstrated significant antiviral effects. In particular, Scutellaria extract inhibits the replication of hepatitis C and influenza A viruses, including H1N1 and H3N2 strains. This inhibition occurs via baicalin, a flavonoid targeting neuraminidase, a crucial enzyme for virus replication. Baicalin inhibits other viruses: HIV-1 infection at the viral entry level and early activation of Epstein-Barr virus antigen. Additionally, Scutellaria inhibits virus replication partly by inhibiting the fusion of viral envelopes with the endosome/lysosome membrane, which occurs early in the virus infection cycle.

Hepato-protective

Baicalin, baicalin, and wogonin, flavonoids of Baikal skullcap, have shown hepatoprotective effects. These compounds reduce toxicity related to various chemicals, as indicated by decreases in liver enzymes (aspartate transaminase [AST] and alanine aminotransferase [ALT]) and histopathological analyses. Baicene, in particular, significantly increases TNF-b1 and IL-6 levels (inflammatory markers), suggesting potential in hepatic regeneration after induced lesions.

Usages associés

Anxiolytic

Research has shown that wogonin, baicalein, scutellarein, and baicalin, all flavonoids, bind to the benzodiazepine site of the GABA-A receptor, with decreasing levels of effectiveness, which plays a role in regulating neuronal excitability and anxiety. Wogonin, taken orally, interacts with these receptors and produces an anxiolytic effect similar to diazepam (an anxiety medication), but without sedation or muscle relaxation. Other flavones like oroxylin A and K36 also act on this site and have shown anxiolytic activity. Additionally, wogonin has anticonvulsant effects mediated by GABA.

Antibacterial

Adding baicene to standard antibiotic therapy against multidrug-resistant Staphylococcus aureus increases the efficacy of the antibiotic ciprofloxacin. This likely occurs because baicene prevents the antibiotic from being ejected out of the bacterium, a common mechanism of bacterial resistance. This discovery offers hope in the treatment of resistant bacterial strains. Furthermore, baicalin and Scutellaria baicalensis have proven effective against Helicobacter pylori, with baicalin being more effective than the complete plant extract.

Hypolipidemic

Animal studies indicate that skullcap can reduce total cholesterol levels, triglycerides, LDL-C (bad cholesterol), while increasing HDL-C (good cholesterol) levels. Additionally, wogonin, a component of skullcap, inhibits MCP-1 production by endothelial cells, suggesting potential benefits in treating inflammatory and vascular disorders, including atherosclerosis.

Antiandrogenic

a0Skullcap is traditionally used for prostate cancer and as an anti-inflammatory agent. In an animal model of benign prostatic hyperplasia, Baikal skullcap inhibited inflammation and cell proliferation, probably by inhibiting 5-alpha reductase.a0

Hypoglycemic

Skullcap may be beneficial in managing diabetes. Human studies have shown that it has a moderate effect on postprandial glucose levels, but not on fasting glucose levels. In animals, baicalin, one of its components, inhibits alpha-glucosidase, an enzyme involved in carbohydrate digestion. Additionally, baicalin appears to reduce elevated insulin levels following a high-fat diet and inhibit intestinal sucrase according to in vitro research.

Usages associés